India to United States: Telmisartan Export Trade Route
India has recorded 447 verified shipments of Telmisartan exported to United States, representing a combined trade value of $20.9M USD. This corridor is served by 16 active Indian exporters, with an average shipment value of $46.7K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 61% of total export value with 108 shipments worth $12.8M USD. On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer in United States with $11.1M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, INVENTIA HEALTHCARE LIMITED, GLENMARK PHARMACEUTICALS LIMITED — together control 89% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Telmisartan corridor is one of India's established pharmaceutical export routes, with 447 shipments documented worth a combined $20.9M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 61% of all export value, reflecting the consolidated nature of India's telmisartan manufacturing sector.
Across 16 active suppliers, the average shipment value stands at $46.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with telmisartan's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 14.3%, placing it at rank #16 among India's top telmisartan export destinations globally.
On the import side, key buyers of Indian telmisartan in United States include MYLAN PHARMACEUTICALS INC,, ASCEND LABORATORIES LLC, MYLAN PHARMACEUTICALS INC and 31 others. MYLAN PHARMACEUTICALS INC, is the single largest importer with 31 shipments valued at $11.1M USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ1
- Primary modeSea freight
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#16
- Annual growth+14.3%
- Demand growth+14.4%
- Regulatory ease89/100
Top 10 Indian Telmisartan Exporters to United States
Showing top 10 of 16 Indian suppliers exporting Telmisartan to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED Avg $118.6K per shipment | 108 | $12.8M | 61.3% |
| 2 | INVENTIA HEALTHCARE LIMITED Avg $27.8K per shipment | 107 | $3.0M | 14.2% |
| 3 | GLENMARK PHARMACEUTICALS LIMITED Avg $21.6K per shipment | 134 | $2.9M | 13.8% |
| 4 | ALEMBIC PHARMACEUTICALS LIMITED Avg $11.8K per shipment | 31 | $366.2K | 1.8% |
| 5 | MICRO LABS LIMITED Avg $40.6K per shipment | 9 | $365.2K | 1.7% |
| 6 | CADILA PHARMACEUTICALS LIMITED Avg $28.1K per shipment | 11 | $309.5K | 1.5% |
| 7 | LUPIN LIMITED Avg $42.4K per shipment | 6 | $254.2K | 1.2% |
| 8 | ZYDUS LIFESCIENCES LIMITED Avg $11.3K per shipment | 22 | $249.4K | 1.2% |
| 9 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED Avg $102.5K per shipment | 2 | $205.0K | 1.0% |
| 10 | GLENMARK PHARMACEUTICALS LTD Avg $25.1K per shipment | 7 | $175.8K | 0.8% |
This table shows the top 10 of 16 Indian companies exporting telmisartan to United States, ranked by total trade value. The listed exporters are: MYLAN LABORATORIES LIMITED, INVENTIA HEALTHCARE LIMITED, GLENMARK PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, MICRO LABS LIMITED, CADILA PHARMACEUTICALS LIMITED, LUPIN LIMITED, ZYDUS LIFESCIENCES LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, GLENMARK PHARMACEUTICALS LTD. MYLAN LABORATORIES LIMITED is the dominant supplier with 108 shipments worth $12.8M USD, giving it a 61% market share. The top 3 suppliers together account for 89% of the total trade value on this route.
Showing top 10 of 16 total Indian exporters on the India to United States Telmisartan export route.
Top 10 Telmisartan Importers in United States
Showing top 10 of 34 known buyers in United States receiving Telmisartan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian telmisartan in United States include MYLAN PHARMACEUTICALS INC,, ASCEND LABORATORIES LLC, MYLAN PHARMACEUTICALS INC, GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS INC USA, among 34 total buyers. The largest importer is MYLAN PHARMACEUTICALS INC,, accounting for $11.1M USD across 31 shipments — representing 53% of all telmisartan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN PHARMACEUTICALS INC, | 31 | $11.1M | 53.3% |
| 2 | ASCEND LABORATORIES LLC | 56 | $2.0M | 9.4% |
| 3 | MYLAN PHARMACEUTICALS INC | 65 | $1.4M | 6.7% |
| 4 | GLENMARK PHARMACEUTICALS INC., USA | 56 | $1.1M | 5.3% |
| 5 | GLENMARK PHARMACEUTICALS INC USA | 18 | $631.6K | 3.0% |
| 6 | EVERSANA LIFE SCIENCE SERVICES LLC | 10 | $489.0K | 2.3% |
| 7 | ASCEND LABORATORIES LLC, | 19 | $480.2K | 2.3% |
| 8 | EVERSANA LIFE SCIENCE SERVICES | 29 | $416.1K | 2.0% |
| 9 | Glenmark Pharmaceuticals Inc USA | 14 | $387.1K | 1.9% |
| 10 | ASCEND LABORATORIES,LLC | 19 | $378.3K | 1.8% |
Showing top 10 of 34 Telmisartan importers in United States on this route.
Top 10 Telmisartan Formulations Imported by United States
Showing top 10 of 267 product formulations shipped on the India to United States Telmisartan route, ranked by trade value
United States imports a wide range of telmisartan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TELMISARTAN TABLETS USP 80 MG 90BT TAB 15168 PACKS — accounts for $5.2M USD across 1 shipments. There are 267 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TELMISARTAN TABLETS USP 80 MG 90BT TAB 15168 PACKS | 1 | $5.2M | 25.1% |
| 2 | TELMISARTAN TABLETS USP 40 MG US 90BT 15225 PACKS | 1 | $2.9M | 13.8% |
| 3 | TELMISARTAN TABLETS USP 40 MG 90BT 10931PACKS | 1 | $2.1M | 9.9% |
| 4 | TELMISARTAN TABLETS USP 40 MG US 30BT 11940 PACKS | 1 | $328.9K | 1.6% |
| 5 | TELMISARTAN TAB 80MG 30 | 15 | $314.2K | 1.5% |
| 6 | TELMISARTAN TABLETS USP 80 MG (30'S) (EACH TABLET CONTAIN TELMISARTAN TABLETS USP 80MG) | 5 | $212.1K | 1.0% |
| 7 | TELMISARTAN TABLETS USP 80 MG 30S NDC 6 | 3 | $164.6K | 0.8% |
| 8 | TELMISARTAN TABLETS USP 80 ANDA NO 207016 NDC NO 42571 228 30 PACK 30S TAX INV NO 706204443 | 1 | $161.5K | 0.8% |
| 9 | TELMISARTAN TAB 40MG 30 | 4 | $155.8K | 0.7% |
| 10 | PHARMACEUTICALS MEDICINES: TELMISARTAN T | 3 | $155.1K | 0.7% |
Showing top 10 of 267 Telmisartan formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 83 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's telmisartan exports to United States are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 108 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 16 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MYLAN LABORATORIES LIMITED, INVENTIA HEALTHCARE LIMITED, GLENMARK PHARMACEUTICALS LIMITED — together account for 89% of total trade value on this route. The average shipment value of $46.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as telmisartan tablets usp 40 mg us 90bt 15225 packs and telmisartan tablets usp 40 mg 90bt 10931packs, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer with 31 shipments worth $11.1M USD — representing 53% of all telmisartan imports from India on this route. A total of 34 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $20.9M
- Avg. Shipment
- $46.7K
- Suppliers
- 16
- Buyers
- 34
- Transit (Sea)
- ~15 days
- Annual Growth
- +14.3%
Related Analysis
Reverse Direction
United States → India — Telmisartan (Import)Other Telmisartan Routes
Unlock the Full India to United States Telmisartan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 447 shipments on this route.
Frequently Asked Questions — India to United States Telmisartan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Telmisartan to United States?
The leading Indian exporters of Telmisartan to United States are MYLAN LABORATORIES LIMITED, INVENTIA HEALTHCARE LIMITED, GLENMARK PHARMACEUTICALS LIMITED. MYLAN LABORATORIES LIMITED holds the largest market share at approximately 61% of total trade value on this route.
Q What is the total value of Telmisartan exports from India to United States?
India exports Telmisartan to United States worth approximately $20.9M USD across 447 recorded shipments. The average value per shipment is $46.7K USD.
Q Which ports does India use to ship Telmisartan to United States?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 83 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to United States for Telmisartan?
The average transit time for Telmisartan shipments from India to United States is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Telmisartan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 14.3% with demand growth tracking at 14.4%. The route is ranked #16 among India's top Telmisartan export destinations globally.
Q How many suppliers are active on the India to United States Telmisartan route?
There are currently 16 active Indian suppliers exporting Telmisartan to United States. The market is moderately concentrated with MYLAN LABORATORIES LIMITED accounting for 61% of total shipment value.
Q Who are the main importers of Telmisartan from India in United States?
The leading importers of Indian Telmisartan in United States include MYLAN PHARMACEUTICALS INC,, ASCEND LABORATORIES LLC, MYLAN PHARMACEUTICALS INC, GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS INC USA. MYLAN PHARMACEUTICALS INC, is the largest buyer with 31 shipments worth $11.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Telmisartan.
- 2.Supplier/Buyer Matching: 16 Indian exporters and 34 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 447 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
447 Verified Shipments
16 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists